Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $13,000 | 3 | 28.9% |
| Consulting Fee | $11,287 | 5 | 25.1% |
| Food and Beverage | $10,890 | 149 | 24.2% |
| Travel and Lodging | $6,120 | 11 | 13.6% |
| Honoraria | $3,091 | 2 | 6.9% |
| Entertainment | $586.95 | 6 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $18,160 | 27 | $0 (2024) |
| Ocular Therapeutix, Inc. | $7,006 | 18 | $0 (2024) |
| Genentech USA, Inc. | $7,006 | 26 | $0 (2024) |
| Apellis Pharmaceuticals, Inc. | $2,316 | 8 | $0 (2024) |
| Alimera Sciences, Inc. | $2,266 | 17 | $0 (2024) |
| Alcon Research Ltd | $1,620 | 3 | $0 (2018) |
| Regeneron Pharmaceuticals, Inc. | $1,422 | 5 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $1,036 | 12 | $0 (2024) |
| Optos, Inc. | $586.95 | 6 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $572.57 | 5 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $36,648 | 97 | Astellas Pharma US Inc ($17,846) |
| 2023 | $2,234 | 42 | Genentech USA, Inc. ($542.20) |
| 2022 | $383.99 | 4 | Bausch & Lomb Americas Inc. ($159.98) |
| 2021 | $716.30 | 8 | Dutch Ophthalmic, USA ($206.24) |
| 2020 | $508.50 | 4 | Regeneron Healthcare Solutions, Inc. ($246.76) |
| 2019 | $1,877 | 14 | Regeneron Pharmaceuticals, Inc. ($734.35) |
| 2018 | $2,608 | 7 | Alcon Research Ltd ($1,620) |
All Payment Transactions
176 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Astellas Pharma US Inc | Izervay (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $7,000.00 | General |
| Category: Ophthalmology | ||||||
| 12/11/2024 | Astellas Pharma US Inc | Izervay (Drug) | Travel and Lodging | Cash or cash equivalent | $915.34 | General |
| Category: Ophthalmology | ||||||
| 12/11/2024 | Astellas Pharma US Inc | Izervay (Drug) | Travel and Lodging | Cash or cash equivalent | $400.39 | General |
| Category: Ophthalmology | ||||||
| 12/11/2024 | Astellas Pharma US Inc | Izervay (Drug) | Travel and Lodging | Cash or cash equivalent | $206.12 | General |
| Category: Ophthalmology | ||||||
| 12/11/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $124.80 | General |
| Category: Ophthalmology | ||||||
| 12/11/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $9.92 | General |
| Category: Ophthalmology | ||||||
| 12/04/2024 | Ocular Therapeutix, Inc. | DEXTENZA (Drug) | Food and Beverage | In-kind items and services | $86.28 | General |
| Category: Corticosteroid intracanalicular insert | ||||||
| 12/03/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $111.69 | General |
| Category: Ophthalmology | ||||||
| 11/22/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/20/2024 | Astellas Pharma US Inc | Izervay (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,000.00 | General |
| Category: Ophthalmology | ||||||
| 11/20/2024 | Ocular Therapeutix, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,200.00 | General |
| 11/20/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $124.12 | General |
| Category: Ophthalmology | ||||||
| 11/18/2024 | Ocular Therapeutix, Inc. | DEXTENZA (Drug) | Food and Beverage | In-kind items and services | $62.99 | General |
| Category: Corticosteroid intracanalicular insert | ||||||
| 11/17/2024 | Ocular Therapeutix, Inc. | DEXTENZA (Drug) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: Corticosteroid intracanalicular insert | ||||||
| 11/17/2024 | Ocular Therapeutix, Inc. | DEXTENZA (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Corticosteroid intracanalicular insert | ||||||
| 11/15/2024 | Ocular Therapeutix, Inc. | — | Travel and Lodging | In-kind items and services | $1,945.84 | General |
| 11/15/2024 | Ocular Therapeutix, Inc. | DEXTENZA (Drug) | Food and Beverage | In-kind items and services | $115.54 | General |
| Category: Corticosteroid intracanalicular insert | ||||||
| 11/15/2024 | Ocular Therapeutix, Inc. | — | Food and Beverage | In-kind items and services | $37.00 | General |
| 11/15/2024 | Ocular Therapeutix, Inc. | — | Food and Beverage | In-kind items and services | $28.00 | General |
| 11/15/2024 | Ocular Therapeutix, Inc. | DEXTENZA (Drug) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: Corticosteroid intracanalicular insert | ||||||
| 11/14/2024 | Ocular Therapeutix, Inc. | — | Food and Beverage | In-kind items and services | $95.00 | General |
| 11/14/2024 | Ocular Therapeutix, Inc. | DEXTENZA (Drug) | Food and Beverage | In-kind items and services | $41.91 | General |
| Category: Corticosteroid intracanalicular insert | ||||||
| 11/12/2024 | Optos, Inc. | NFC-700 (Device), PANORAMIC OPHTHALMOSCOPE, OCT OPHTHALMOSCOPE | Entertainment | In-kind items and services | $92.98 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/30/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $26.85 | General |
| Category: Ophthalmology | ||||||
| 10/28/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $44.08 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 948 | 27,965 | $778,179 | $419,211 |
| 2022 | 9 | 322 | 896 | $515,155 | $158,208 |
| 2021 | 5 | 138 | 193 | $53,045 | $13,554 |
| 2020 | 1 | 15 | 20 | $3,320 | $713.55 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 52 | 7,260 | $317,117 | $207,971 | 65.6% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 33 | 132 | $170,886 | $91,250 | 53.4% |
| J3490 | Unclassified drugs | Office | 2023 | 12 | 17 | $55,000 | $29,337 | 53.3% |
| 67028 | Injection of drug into eye | Office | 2023 | 98 | 228 | $52,074 | $21,567 | 41.4% |
| 92134 | Imaging of retina | Office | 2023 | 230 | 434 | $34,913 | $14,399 | 41.2% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 98 | 122 | $26,406 | $12,471 | 47.2% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 68 | 155 | $46,500 | $11,529 | 24.8% |
| J2403 | Chloroprocaine hcl ophthalmic, 3% gel, 1 mg | Office | 2023 | 23 | 19,200 | $16,896 | $10,543 | 62.4% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 78 | 78 | $21,327 | $9,468 | 44.4% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 134 | 194 | $8,647 | $3,901 | 45.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 27 | 32 | $12,718 | $3,148 | 24.8% |
| 92250 | Photography of the retina | Office | 2023 | 63 | 78 | $10,745 | $2,360 | 22.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 15 | $4,380 | $1,024 | 23.4% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 19 | 20 | $570.20 | $242.25 | 42.5% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 13 | 146 | $295,504 | $104,660 | 35.4% |
| 67028 | Injection of drug into eye | Office | 2022 | 25 | 128 | $50,432 | $14,245 | 28.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 57 | 112 | $47,152 | $12,409 | 26.3% |
| 92134 | Imaging of retina | Office | 2022 | 57 | 172 | $27,176 | $6,641 | 24.4% |
| 92250 | Photography of the retina | Office | 2022 | 72 | 155 | $27,280 | $5,361 | 19.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 31 | 57 | $16,644 | $5,016 | 30.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 31 | 31 | $19,902 | $4,764 | 23.9% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2022 | 14 | 49 | $22,785 | $2,618 | 11.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 22 | 46 | $8,280 | $2,494 | 30.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 38 | 55 | $23,155 | $6,313 | 27.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 14 | 14 | $8,988 | $2,305 | 25.6% |
About Dr. Michael Jansen, M.D
Dr. Michael Jansen, M.D is a Ophthalmology healthcare provider based in Denver, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/14/2013. The National Provider Identifier (NPI) number assigned to this provider is 1265878466.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Jansen, M.D has received a total of $44,975 in payments from pharmaceutical and medical device companies, with $36,648 received in 2024. These payments were reported across 176 transactions from 28 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($13,000).
As a Medicare-enrolled provider, Jansen has provided services to 1,423 Medicare beneficiaries, totaling 29,074 services with total Medicare billing of $591,685. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmology
- Location Denver, CO
- Active Since 05/14/2013
- Last Updated 10/06/2025
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1265878466
Products in Payments
- Izervay (Drug) $16,990
- Susvimo (Drug) $3,575
- Vabysmo (Drug) $3,170
- ILUVIEN (Drug) $1,621
- DEXTENZA (Drug) $1,082
- EYLEA (Biological) $864.37
- YUTIQ (Drug) $769.42
- NFC-700 (Device) $486.47
- Syfovre (Drug) $462.75
- EVA Ophthalmic Surgical System (Device) $351.03
- ACTHAR (Biological) $251.47
- BEOVU (Drug) $237.63
- EVA, combined machine (Device) $190.94
- EYLEA HD (Biological) $171.47
- OZURDEX (Drug) $170.09
- XIPERE (Drug) $159.98
- ARTEVO 800 (Device) $156.89
- Luxor (Device) $149.84
- VABYSMO (Drug) $148.66
- LUMIGAN (Drug) $122.41
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Denver
Mr. Jerry Popham, M.d, M.D
Ophthalmology — Payments: $799,779
Jack Zamora, Md, MD
Ophthalmology — Payments: $666,046
Alan Kimura, Md, MD
Ophthalmology — Payments: $589,846
Dr. Cristos Ifantides, M.d, M.D
Ophthalmology — Payments: $143,630
Brian Joondeph, Md, MD
Ophthalmology — Payments: $108,464
Dr. Eva Kim, Md, MD
Ophthalmology — Payments: $65,451